These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2831454)

  • 1. Antigenic hybrids of poliovirus.
    Hogle JM
    Nature; 1988 Mar; 332(6159):13-4. PubMed ID: 2831454
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines based on recombinant antigen strategies.
    Minor P
    Dev Biol (Basel); 2001; 105():189-94. PubMed ID: 11763327
    [No Abstract]   [Full Text] [Related]  

  • 3. [Variability of poliomyelitis virus strains in nature and significance of this factor for the prevention of poliomyelitis].
    Gendon IuZ
    Vopr Virusol; 1988; 33(2):137-41. PubMed ID: 2457986
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.
    Martín J; Samoilovich E; Dunn G; Lackenby A; Feldman E; Heath A; Svirchevskaya E; Cooper G; Yermalovich M; Minor PD
    J Virol; 2002 Nov; 76(21):10921-8. PubMed ID: 12368335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus vaccines.
    Racaniello VR
    Biotechnology; 1992; 20():205-22. PubMed ID: 1318134
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivated poliovirus vaccine and vaccine-associated paralytic poliomyelitis.
    Brown B
    JAMA; 1997 Jan 22-29; 277(4):295. PubMed ID: 9002483
    [No Abstract]   [Full Text] [Related]  

  • 7. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of poliomyelitis: a continuing paradox.
    Horstmann DM
    J Infect Dis; 1982 Oct; 146(4):540-51. PubMed ID: 6288809
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of antigenic properties of vaccine derived poliovirus strains.
    Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
    Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines.
    Conrad DA; Jenson HB
    Postgrad Med; 1997 Nov; 102(5):45-8, 51-3, 59-60 passim. PubMed ID: 9385331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to the construction of new candidate poliovirus type 3 vaccine strains.
    Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD
    Dev Biol Stand; 1993; 78():161-9; discussion 169-70. PubMed ID: 8388827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.
    Horaud F
    Dev Biol Stand; 1993; 78():149-54; discussion 154-5. PubMed ID: 8388825
    [No Abstract]   [Full Text] [Related]  

  • 15. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.
    Whelan SP; Evans D; Almond JW
    Dev Biol Stand; 1995; 84():129-36. PubMed ID: 7796945
    [No Abstract]   [Full Text] [Related]  

  • 16. Markers of poliovirus strains isolated from cases temporally associated with the use of live poliovirus vaccine: report on a W.H.O. collaborative study.
    J Biol Stand; 1981; 9(2):163-84. PubMed ID: 6165725
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine-associated poliomyelitis cases.
    Sabin AB
    Bull World Health Organ; 1969; 40(6):947-9. PubMed ID: 5307605
    [No Abstract]   [Full Text] [Related]  

  • 18. Polio vaccines: WHO position paper – March, 2016.
    Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivated vaccines based on alternatives to wild-type seed virus.
    Chumakov K; Dragunsky E; Ivshina A; Enterline J; Wells V; Nomura T; Gromeier M; Wimmer E
    Dev Biol (Basel); 2001; 105():171-7. PubMed ID: 11763325
    [No Abstract]   [Full Text] [Related]  

  • 20. Design, construction, and characterization of poliovirus antigen chimeras.
    Evans DJ; Almond JW
    Methods Enzymol; 1991; 203():386-400. PubMed ID: 1662331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.